Botanical Ingredient Producer Linnea SA Celebrates 40 Years

The global cannabinoid market is projected to from $28.26 billion in 2021 to $197.74 billion in 2028 at a compound annual growth rate, CAGR, of 32.04%. One mature and seasoned company that entered the market in 2016 is Linnea SA. 

This year marks Linnea’s 40th anniversary manufacturing high quality natural botanical ingredients for use in the pharmaceutical, cosmetics and dietary supplement industries. Linnea produces high quality botanical ingredients like Bilberry, Ginkgo Biloba, Red Clover, 5 HTP, HMR Lignan™, Vinpocetine, Vincamine, and Butylscopolamine at their GMP-certified facility in Ticino, Switzerland. Since 2016 Linnea Cannabinoids has been focusing on delivering non-psychoactive cannabinoids like Cannabidiol (CBD) and Cannabigerol (CBG). Linnea was the first company worldwide to get a GMP certificate for a CBD extract in 2016. 

The benefits of established pharmaceutical companies like Linnea taking root in the cannabinoid industry are of immense importance to product manufacturers and, by extension, the people they serve. The use of truly high quality and standardized ingredients in cannabinoid products will set brands apart at this stage in the industry’s evolution. Delivering a reliable, consistent, and beneficial consumer experience by utilizing trustworthy ingredients like Linnea’s will generate long term patient and doctor loyalty. When have a product with ingredients that are standardized they get the same exact cannabinoids, dose, stability …

Full story available on

More Botanical Ingredient Producer Linnea SA Celebrates 40 Years